Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome-Reference-Cited by-同舟云学术

Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

Published:2022-03-11 Issue:3 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Jacobsen Audrey¹,Olabi Bayanne²,Langley Annie³,Beecker Jennifer³,Mutter Eric⁴,Shelley Amanda⁵,Worley Brandon⁶,Ramsay Timothy⁷,Saavedra Arturo⁸,Parker Roses⁹,Stewart Fiona¹⁰,Pardo Pardo Jordi¹¹

Affiliation:

1. Department of Dermatology; University of Minnesota Medical School; Minneapolis MN USA

2. Department of Dermatology; Lothian University Hospitals NHS Trust, Lauriston Building; Edinburgh UK

3. Division of Dermatology, Department of Medicine; The Ottawa Hospital and the University of Ottawa; Ottawa Canada

4. Department of Emergency Medicine; The Ottawa Hospital; Ottawa Canada

5. Division of Dermatology; University of Toronto; Toronto Canada

6. Florida Dermatology and Skin Cancer Centers; Lake Wales Florida USA

7. Clinical Epidemiology Program; Ottawa Hospital Research Institute; Ottawa Canada

8. Department of Dermatology; University of Virginia Health System; Charlottesville USA

9. Musculoskeletal, Oral, Skin and Sensory Network; Oxford University Hospitals NHS Foundation Trust Second Floor, OUH Cowley Unipart House Business Centre; Oxford UK

10. Cochrane Children and Families Network, c/o Cochrane Pregnancy and Childbirth, Department of Women's and Children's Health; The University of Liverpool; Liverpool UK

11. Ottawa Hospital Research Institute, The Ottawa Hospital - General Campus; Ottawa Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference141 articles.

1. Role of systemic steroids in the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis;Azfar;Journal of Pakistan Association of Dermatologists,2010

2. Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches;González-Herrada;Journal of Investigative Dermatology,2017

3. Han F Zhang J Guo Q Feng Y Gao Y Guo L Successful treatment of toxic epidermal necrolysis using plasmapheresis: a prospective observational study Journal of Critical Care 2017 42 65 8

4. Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 cases;Jagadeesan;Indian Journal of Dermatology, Venereology and Leprology,2013

5. Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children;Kakourou;European Journal of Pediatrics,1997

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and chronic ocular outcomes in SJS/TEN patients treated with oral ciclosporin vs intravenous immunoglobulin;Frontiers in Medicine;2024-08-19

2. Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study;Frontiers in Immunology;2024-08-07

3. Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions;Cureus;2024-07-16

4. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

5. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis;The American Journal of Emergency Medicine;2024-07